Empirical Characteristics of Litigation Involving Tissue Plasminogen Activator and Ischemic Stroke

Annals of Emergency Medicine

Volumn 52, Issue 2, 2008, Pages 160-164

  Liang, Bryan A ^a,b,c,e,f   Zivin, Justin A ^d  

^a CALIFORNIA WESTERN SCHOOL OF LAW   (United States)

^b San Diego Center for Patient Safety   (United States)

^c Department of Anesthesiology ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Center for Public Health Security   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; EMERGENCY MEDICINE; EMERGENCY PHYSICIAN; HUMAN; LAW SUIT; MEDICAL LIABILITY; MEDICOLEGAL ASPECT; PRIORITY JOURNAL;

BRAIN ISCHEMIA; HUMANS; JURISPRUDENCE; MALPRACTICE; STROKE; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 48949117567     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.12.017     Document Type: Article

References (10)

1. Demaerschalk B.M. Thrombolytic therapy for acute ischemic stroke, the likelihood of being helped versus harmed. Stroke 38 (2007) 2215-2216
2. Brown D.L., Barsan W.G., Lisabeth L.D., et al. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Amerg Med 46 (2005) 56-60
3. Glauser J. Will EPs' reluctance to embrace thrombolysis for stroke lead to lawsuits [part I]?. Emerg Med News 28 (2006) 23-25
4. Glauser J. Will EPs' reluctance to embrace thrombolysis for stroke lead to lawsuits [part II]?. Emerg Med News 28 (2006) 28-29
5. Glauser J. Stroke and the emergency physician: is tPA standard of care?. Emerg Med News 29 (2007) 1 24-25
6. Kleindorfer D., Kissela B., Schneider A., et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 35 (2004) e27-e29
7. Schneider SM, Goldstein LB, Adams JG, et al. Incentives for enhancing stroke care. In: A National Institute of Neurological Disorders and Stroke Symposium: Improving the Chain of Recovery for Acute Stroke in Your Community-Task Force Reports. Bethesda, MD: National Institutes of Health, Department of Health and Human Services; 2002:71-80.
8. Bambauer K.Z., Johnston C., Bambauer D.E., et al. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 63 (2006) 661-664
9. Weintraub M.I. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke 37 (2006) 1917-1922
10. Liang B.A. Layperson and physician perceptions of the malpractice system: implications for patient safety. Soc Sci Med 57 (2003) 147-153